Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma - Nature Medicine

Australia News News

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma - Nature Medicine
Australia Latest News,Australia Headlines
  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 53%

Multi-omics analysis of tumors from phase 1b GO30140 and phase 3 IMbrave150 trials reveals immune and genetic features in patients with advanced hepatocellular carcinoma who might benefit from atezolizumab and bevacizumab combination therapy genentech

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Kaplan-Meier estimates of progression-free survival and overall survival in patients in the ITT and BEP of, IMbrave150 . Stratified hazard ratios and two-sided log-likelihoodvalues for progression or death are reported. 95% confidence intervals are indicated in parentheses.

Extended Data Fig. 3 Key biomarker expression by RECIST response and PFS/OS association within treatment groups of IMbrave150., Expression of ABRS, CD274 and Teff signature score by RECIST response in IMbrave150 Atezo-Bev treatment group . Box plots are of log2 gene expression scores for response categories, with two-sided P values from Student t tests. Boxes represent median and first/third quartile values. Box whiskers represent the most extreme values within 150% of the interquartile range.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NatureMedicine /  🏆 451. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Peter Chernin Launching $1B+ Content Studio Rollup The North Road CompanyPeter Chernin Launching $1B+ Content Studio Rollup The North Road CompanyNorth Road will house Chernin Entertainment; U.S. assets of Red Arrow Studios; and Words + Pictures, with more acquisitions to follow.
Read more »

Hacker claims to have stolen 1B records of Chinese citizens from policeHacker claims to have stolen 1B records of Chinese citizens from policeHacker claims to have stolen personal information from the Shanghai police on 1 billion Chinese citizens, which tech experts say, if true, would be one of the biggest data breaches in history.
Read more »

The promise of precision medicine in rheumatology - Nature MedicineThe promise of precision medicine in rheumatology - Nature MedicinePrecision medicine for rheumatic diseases is still in its infancy, but recent advances are enabling comprehensive profiling and mechanistic insights. This Review outlines the progress, promises, and challenges of translating these findings into the clinic.
Read more »

A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs - Nature BiotechnologyA multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs - Nature BiotechnologyA multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Read more »

Police reveal two prior run-ins with alleged Highland Park shooterPolice reveal two prior run-ins with alleged Highland Park shooterThe suspected gunman in the deadly shooting at an Independence Day parade in Highland Park, Illinois, had prior contact with law enforcement, police said Tuesday.
Read more »

Uvalde officer asked permission to shoot gunman outside school but got no answer, report findsUvalde officer asked permission to shoot gunman outside school but got no answer, report findsAn Uvalde police officer could have shot at the gunman before he entered Robb Elementary School and killed 21 people. But a request for permission either went unanswered or was answered too late, according to a newly released report.
Read more »



Render Time: 2025-03-03 15:26:09